Shigeki Ito

Iwate Medical University — Japan

Medicine · Health Sciences

28h-index3.2kcitations293works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(64), Chronic Lymphocytic Leukemia Research(28), Medical Imaging Techniques and Applications(21), Radiation Detection and Scintillator Technologies(19), T-cell and Retrovirus Studies(19)

Publications292 total

Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 study
International Journal of Hematology·2025Open Access
Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)
International Journal of Hematology·2025Open Access
Comparison of Image Quality of Breast-Specific Positron Emission Tomography: Insights from Phantom and Clinical Studies in a Japanese Multicenter Trial
2025Open Access
Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study
Blood·2025Open Access
Multiple myeloma with ≥1% circulating plasma cells in peripheral blood has a poor prognosis
Blood·2025
Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study
Clinical Lymphoma Myeloma & Leukemia·2025
Integration of Imaging Capability Into a Forceps-Type Mini-PET System: A Simulation Study
2025
Micro RI Cell Imaging System Using Eutectic Scintillator and Objective Lens
2025
NEMA NU4 Performance Evaluation of Mirai-PET: Small Animal PET with CLS TOF-DOI Detectors
2025
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)
Blood Cancer Journal·2025Open Access
Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a Japanese expert panel
Japanese Journal of Clinical Oncology·2025· 1 citedOpen Access
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myeloma
International Journal of Hematology·2025
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)
International Journal of Hematology·2025· 1 cited
Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM
International Journal of Hematology·2025· 1 citedOpen Access
Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen
Journal of Clinical and Experimental Hematopathology·2025Open Access
[Adult T-cell leukemia/lymphoma treated with mogamulizumab followed by allogeneic stem cell transplantation after bridging therapy with valemetostat].
PubMed·2025
Magnetic resonance imaging findings of intravascular large B-cell lymphoma mimicking fasciitis of the thigh: A case report
Journal of Clinical and Experimental Hematopathology·2025Open Access
Efficacy and Safety of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Japanese Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 Monumental-1 Study
Blood·2024Open Access
Dynamic micro RI Imaging System Using Eutectic Scintillation Crystal with Micro Fiber Structure
2024
Mirai-PET: High-Resolution, Portable, Axially Long Small Animal PET with TOF-DOI Detection
2024
page 1 of 15Next →

Frequent Co-authors

Yoji Ishida(12), Manohar M. Panjabi(11), Paul C. Ivancic(11), Kazunori Murai(9), Kenichi Ishizawa(5), Adam M. Pearson(5), Tatsuo Oyake(5), Junji Tanaka(4), Kenji Shimazoe(4), Hiroyuki Takahashi(4), Masao Yoshino(4), Kei Kamada(4), Akira Yoshikawa(4), Shugo Kowata(4), Kisato Nosaka(3), Yoshitaka Imaizumi(3), Kunihiro Tsukasaki(3), Takanori Endo(3), Hiroki Sato(3), Y. Usuki(3)